Samer S Najjar

Summary

Country: USA

Publications

  1. ncbi Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial
    Samer S Najjar
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
    JAMA 305:1863-72. 2011

Detail Information

Publications1

  1. ncbi Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial
    Samer S Najjar
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
    JAMA 305:1863-72. 2011
    ..Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function...